Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Knight Therapeutics Inc
KHTRF
Primary Symbol:
T.GUD
Healthcare
Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select...
international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:GUD)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
(1)
•••
Stockoman1
X
View Profile
View Bullboard History
Comment by
Stockoman1
on Apr 06, 2023 6:11am
RE:Here ... I'll change the header ...
We have been here a long,long,long,long,long time already !!
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Post by
MrMugsy
on Apr 05, 2023 7:03pm
Here ... I'll change the header ...
Well said Schocor ! I like the way you think. Hard to argue with $40 MM in cash coming into the bank account annually. Loss just means we don't pay tax. $340+ MM in cash, marketable securities
...more
(125)
•••
schocor
X
View Profile
View Bullboard History
Comment by
schocor
on Apr 04, 2023 6:12pm
RE:RE:RE:GUD correlation with Paladin = zero
Amazon didnt have profits for years - were THEY a good investmetn?
(3)
•••
Chianchin
X
View Profile
View Bullboard History
Comment by
Chianchin
on Apr 04, 2023 5:32pm
RE:RE:GUD correlation with Paladin = zero
but no profits
(125)
•••
schocor
X
View Profile
View Bullboard History
Comment by
schocor
on Apr 04, 2023 3:24pm
RE:GUD correlation with Paladin = zero
I don't think this comment (header) makes any sense. Can yuo explain why there is no correlation between companies that share directors and a general busienss model?
(13)
•••
gudisgood
X
View Profile
View Bullboard History
Comment by
gudisgood
on Apr 03, 2023 2:25am
RE:giudisgood alias
I'm not trying to "fool investors" -- LOL. I'm discussing the company here in an area dedicated to this company. What else are you supposed to do here? If you don't like the
...more
(3)
•••
Chianchin
X
View Profile
View Bullboard History
Post by
Chianchin
on Apr 02, 2023 5:40pm
giudisgood alias
Just think about it for a moment ...after losing fortunes these actors with multiple aliases are so original and objective thinkers and "financialy bankrupt" so they think that can
...more
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Comment by
MrMugsy
on Apr 02, 2023 11:40am
RE:GUD correlation with Paladin = zero
Oh my Chi-Chi ... if you're going to quote numbers you really should be more accurate. - not ten years ... it's been 8 years of revenue growth. - did not go "all-in" but decided that
...more
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Comment by
MrMugsy
on Apr 02, 2023 10:49am
RE:RE:Paladin Labs' Revenue Guidance (2007-2012)
GUD knows what they purchased - they know the GM concerns and they know the work they need to do on the financial side. Nothing drastic is happening overnight. It's a process. It
...more
(3)
•••
Chianchin
X
View Profile
View Bullboard History
Post by
Chianchin
on Apr 02, 2023 10:09am
GUD correlation with Paladin = zero
GUD went all in LATAM with 3/4 of a Billion dollar. Insane GUD regardles of increasing sales cannot make a dime profit. Latam does not let grinkos mae profits and they will take you to the
...more
(6)
•••
curiousj
X
View Profile
View Bullboard History
Comment by
curiousj
on Apr 02, 2023 9:22am
RE:Paladin Labs' Revenue Guidance (2007-2012)
gap still remains between Paladin's margins and Knight's. what's weighing on Knight is amortization is high and GM are low, they paid for GBT and license agreements have too high royalties
...more
(6)
•••
curiousj
X
View Profile
View Bullboard History
Comment by
curiousj
on Apr 02, 2023 9:17am
RE:RE:RE:RE:Paladin Labs' Revenue Guidance (2007-2012)
2013 number was $276 850 included the pharmaplan acq/litha
(13)
•••
gudisgood
X
View Profile
View Bullboard History
Comment by
gudisgood
on Apr 01, 2023 2:56pm
RE:RE:RE:Paladin Labs' Revenue Guidance (2007-2012)
Just noticed I have the 2012 revenue number is excluding Litha in my Excel. With Litha's numbers, revenues were $210 200.
(13)
•••
gudisgood
X
View Profile
View Bullboard History
Comment by
gudisgood
on Apr 01, 2023 2:51pm
RE:RE:Paladin Labs' Revenue Guidance (2007-2012)
In 2003, revenue was almost even, other than that seemed to have been decent growth every year. Operating cash flow was a different case though... years of positive growth, negative growth and zero
...more
Prev
...
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >